IGF-1 Regulates Vertebral Bone Aging Through Sex-Specific and Time-Dependent Mechanisms

Journal of Bone and Mineral Research

Volumn 31, Issue 2, 2016, Pages 443-454

  Ashpole, Nicole M ^a   Herron, Jacquelyn C ^b   Mitschelen, Matthew C ^a   Farley, Julie A ^a   Logan, Sreemathi ^a   Yan, Han ^a   Ungvari, Zoltan ^a   Hodges, Erik L ^a   Csiszar, Anna ^a   Ikeno, Yuji ^c   Humphrey, Mary Beth ^b,d   Sonntag, William E ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

AGING; BONE HISTOMORPHOMETRY; BONE CT; IGF 1; OSTEOPROTEGERIN

Indexed keywords

INSULIN RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; SOMATOMEDIN C; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; TNFSF11 PROTEIN, MOUSE;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE AGE; BONE DENSITY; BONE MASS; BONE STRUCTURE; CONTROLLED STUDY; FEMALE; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SPINE FRACTURE; TIME; TRABECULAR BONE; VERTEBRA; AGING; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; OSTEOPOROSIS; SEXUAL DEVELOPMENT; SPINE; TIME FACTOR; TRANSGENIC MOUSE;

AGING; ANIMALS; BONE DENSITY; FEMALE; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, TRANSGENIC; OSTEOPOROSIS; RANK LIGAND; RECEPTOR, INSULIN; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; SPINE; TIME FACTORS;

EID: 84959558077     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2689     Document Type: Article

References (67)

1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A., Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007; 22 (3): 465-75.
2. Birkhold AI, Razi H, Duda GN, Weinkamer R, Checa S, Willie BM., The influence of age on adaptive bone formation and bone resorption. Biomaterials. 2014; 35 (34): 9290-301.
3. Seeman E., Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int. 2003;14 Suppl 3: S2-8.
4. Seeman E., Structural basis of growth-related gain and age-related loss of bone strength. Rheumatology (Oxford). 2008;47 Suppl 4: iv2-8.
5. Sheng MH, Lau KH, Baylink DJ., Role of osteocyte-derived insulin-like growth factor i in developmental growth, modeling, remodeling, and regeneration of the bone. J Bone Metab. 2014; 21 (1): 41-54.
6. Crane JL, Cao X., Function of matrix IGF-1 in coupling bone resorption and formation. J Mol Med. 2014; 92 (2): 107-15.
7. Hayden JM, Mohan S, Baylink DJ., The insulin-like growth factor system and the coupling of formation to resorption. Bone. 1995;17 (2 Suppl): 93S-8S.
8. Khosla S, Oursler MJ, Monroe DG., Estrogen and the skeleton. Trends Endocrinol Metab. 2012; 23 (11): 576-81.
9. Frenkel B, Hong A, Baniwal SK, et al., Regulation of adult bone turnover by sex steroids. J Cell Physiol. 2010; 224 (2): 305-10.
10. Manolagas SC, Kousteni S, Jilka RL., Sex steroids and bone. Recent Prog Horm Res. 2002; 57: 385-409.
11. Langlois JA, Rosen CJ, Visser M, et al., Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab. 1998; 83 (12): 4257-62.
12. Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG., Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int. 2002; 70 (1): 22-9.
13. Janssen JA, Burger H, Stolk RP, et al., Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol. 1998; 138 (6): 627-32.
14. Szulc P, Joly-Pharaboz MO, Marchand F, Delmas PD., Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Calcif Tissue Int. 2004; 74 (4): 322-9.
15. Rhee EJ, Oh KW, Lee WY, et al., Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men. J Bone Miner Metab. 2004; 22 (4): 392-8.
16. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K., Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res. 1997; 12 (8): 1272-9.
17. Kurland ES, Rosen CJ, Cosman F, et al., Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab. 1997; 82 (9): 2799-805.
18. Mohamad MI, Khater MS., Evaluation of insulin like growth factor-1 (IGF-1) level and its impact on muscle and bone mineral density in frail elderly male. Arch Gerontol Geriatr. 2015; 60 (1): 124-7.
19. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A., Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993; 75 (1): 59-72.
20. Wang Y, Nishida S, Sakata T, et al., Insulin-like growth factor-I is essential for embryonic bone development. Endocrinology. 2006; 147 (10): 4753-61.
21. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ., Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 1996; 335 (18): 1363-7.
22. Baker J, Liu JP, Robertson EJ, Efstratiadis A., Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993; 75 (1): 73-82.
23. Bikle D, Majumdar S, Laib A, et al., The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res. 2001; 16 (12): 2320-9.
24. Zhang M, Xuan S, Bouxsein ML, et al., Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002; 277 (46): 44005-12.
25. Kubota T, Elalieh HZ, Saless N, et al., Insulin-like growth factor-1 receptor in mature osteoblasts is required for periosteal bone formation induced by reloading. Acta Astronaut. 2013; 92 (1): 73-8.
26. Sjogren K, Sheng M, Moverare S, et al., Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. J Bone Miner Res. 2002; 17 (11): 1977-87.
27. Courtland HW, Elis S, Wu Y, et al., Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner. PLoS One. 2011; 6 (3):e 14762.
28. Yakar S, Canalis E, Sun H, et al., Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J Bone Miner Res. 2009; 24 (8): 1481-92.
29. Courtland HW, Kennedy OD, Wu Y, et al., Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging. Age. 2013; 35 (5): 1691-703.
30. Gong Z, Kennedy O, Sun H, et al., Reductions in serum IGF-1 during aging impair health span. Aging Cell. 2014; 13 (3): 408-18.
31. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR., Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1993; 76 (1): 134-8.
32. Bando H, Zhang C, Takada Y, Yamasaki R, Saito S., Impaired secretion of growth hormone-releasing hormone, growth hormone and IGF-I in elderly men. Acta Endocrinol (Copenh). 1991; 124 (1): 31-6.
33. Niblock MM, Brunso-Bechtold JK, Lynch CD, Ingram RL, McShane T, Sonntag WE., Distribution and levels of insulin-like growth factor I mRNA across the life span in the Brown Norway x Fischer 344 rat brain. Brain Res. 1998; 804 (1): 79-86.
34. Smith CP, Dunger DB, Williams AJ, et al., Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab. 1989; 68 (5): 932-7.
35. Sonntag WE, Ramsey M, Carter CS., Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev. 2005; 4 (2): 195-212.
36. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL., Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A. 1998; 95 (26): 15603-7.
37. Rudman D, Feller AG, Nagraj HS, et al., Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990; 323 (1): 1-6.
38. Bartke A, Brown-Borg H., Life extension in the dwarf mouse. Curr Topics Dev Biol. 2004; 63: 189-225.
39. Bartke A, Chandrashekar V, Dominici F, et al., Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontology. 2003; 4 (1): 1-8.
40. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A., Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology. 2005; 146 (2): 851-60.
41. Liu JM, Zhao HY, Ning G, et al., IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women. J Bone Miner Metab. 2008; 26 (2): 159-64.
42. Paccou J, Dewailly J, Cortet B., Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis. Joint Bone Spine. 2012; 79 (1): 78-82.
43. Yakar S, Liu JL, Stannard B, et al., Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A. 1999; 96 (13): 7324-9.
44. Toth P, Tucsek Z, Tarantini S, et al., IGF-1 deficiency impairs cerebral myogenic autoregulation in hypertensive mice. J Cereb Blood Flow Metab. 2014 Dec;34(12): 1887-97.
45. Mocsai A, Humphrey MB, Van Ziffle JA, et al., The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004; 101 (16): 6158-63.
46. Torchia EC, Stolz A, Agellon LB., Differential modulation of cellular death and survival pathways by conjugated bile acids. BMC Biochem. 2001; 2: 11.
47. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25 (7): 1468-86.
48. Dempster DW, Compston JE, Drezner MK, et al., Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013; 28 (1): 2-17.
49. Yakar S, Liu JL, Fernandez AM, et al., Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes. 2001; 50 (5): 1110-8.
50. Halloran BP, Ferguson VL, Simske SJ, Burghardt A, Venton LL, Majumdar S., Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res. 2002; 17 (6): 1044-50.
51. He J, Rosen CJ, Adams DJ, Kream BE., Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone. 2006; 38 (6): 826-35.
52. Tahimic CG, Wang Y, Bikle DD., Anabolic effects of IGF-1 signaling on the skeleton. Front Endocrinol. 2013; 4: 6.
53. Ashpole NM, Sanders JE, Hodges EL, Yan H, Sonntag WE., Growth hormone, insulin-like growth factor-1 and the aging brain. Exp Gerontol. 2015 Aug;68: 76-81.
54. List EO, Berryman DE, Funk K, et al., Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. Endocrinology. 2014; 155 (5): 1793-805.
55. Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL, Clemens TL., Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem. 2007; 282 (35): 25649-58.
56. Fulzele K, Clemens TL., Novel functions for insulin in bone. Bone. 2012; 50 (2): 452-6.
57. Bord S, Ireland DC, Beavan SR, Compston JE., The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone. 2003; 32 (2): 136-41.
58. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL., Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. 1999; 140 (9): 4367-70.
59. Sonntag WE, Carter CS, Ikeno Y, et al., Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology. 2005; 146 (7): 2920-32.
60. Riggs BL, Melton LJ 3rd, Robb RA, et al., Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004; 19 (12): 1945-54.
61. Courtland HW, Sun H, Beth-On M, et al., Growth hormone mediates pubertal skeletal development independent of hepatic IGF-1 production. J Bone Miner Res. 2011; 26 (4): 761-8.
62. Yakar S, Setser J, Zhao H, et al., Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest. 2004; 113 (1): 96-105.
63. Boni-Schnetzler M, Hauri C, Zapf J., Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats. Diabetologia. 1999; 42 (2): 160-6.
64. Turner RT, Kalra SP, Wong CP, et al., Peripheral leptin regulates bone formation. J Bone Miner Res. 2013; 28 (1): 22-34.
65. Eckstein F, Matsuura M, Kuhn V, et al., Sex differences of human trabecular bone microstructure in aging are site-dependent. J Bone Miner Res. 2007; 22 (6): 817-24.
66. Lochmuller EM, Matsuura M, Bauer J, et al., Site-specific deterioration of trabecular bone architecture in men and women with advancing age. J Bone Miner Res. 2008; 23 (12): 1964-73.
67. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML,. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res. 2007; 22 (8): 1197-207.